Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.48 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 5/20 | 0.48 |
| ▸ | PPARD | Q03181 | 5/20 | 0.48 |
| ▸ | PPARA | Q07869 | 5/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL138223 | 1.00 | CES2 (0.68) | CES2MEN1KMT2ATHRBHTT | |
| Acetic Acid SCHEMBL4930252 | 1.00 | CES2 (0.68) | CES2MEN1KMT2ATHRBHTT | |
| Acetic Acid SCHEMBL353029 | 1.00 | CES2 (0.68) | CES2MEN1KMT2ATHRBHTT | |
| Acetic Acid SCHEMBL2400937 | 1.00 | CES2 (0.68) | CES2MEN1KMT2ATHRBHTT | |
| Acetic Acid SCHEMBL3426392 | 1.00 | CES2 (0.68) | CES2MEN1KMT2ATHRBHTT | |
| Acetic Acid SCHEMBL3139068 | 1.00 | CES2 (0.68) | CES2MEN1KMT2ATHRBHTT | |
| Acetic Acid SCHEMBL537713 | 1.00 | CES2 (0.68) | CES2MEN1KMT2ATHRBHTT | |
| Acetic Acid SCHEMBL9550103 | 0.98 | CES2 (0.65) | CES2MEN1KMT2ATHRBHTT | |
| Acetic Acid SCHEMBL3264543 | 0.97 | CES2 (0.64) | CES2MEN1KMT2ATHRBHTT | |
| Acetic Acid SCHEMBL28328015 | 0.95 | CES2 (0.61) | CES2MEN1KMT2ATHRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260064038-A1 | DEVELOPING ROLLER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS | CANON KK (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260050231-A1 | PROCESS CARTRIDGE | CANON KK (JP) | 2026-02-19 | — | — | US | disclosed |
| EP-3443951-B1 | SUPERFATTING AGENT AND PERSONAL CARE COMPOSITION | SABO SPA (IT) | 2022-09-21 | — | — | EP | disclosed |
| CN-108883049-B | Superfatting agents and personal care compositions | 萨博公司 | 2021-03-12 | — | — | CN | disclosed |
| EP-3443951-A1 | SUPERFATTING AGENT AND PERSONAL CARE COMPOSITION | Sabo S.p.A. (IT) | 2019-02-20 | — | — | EP | disclosed |
| EP-1799631-B1 | HYDROXYCITRIC ACID DERIVATIVES AND SKIN EXTERNAL PREPARATIONS CONTAINING THE SAME | SHOWA DENKO KK (JP) | 2017-01-25 | — | — | EP | disclosed |
| EP-2642975-B1 | SKIN EXTERNAL PREPARATION AND METHOD OF PRODUCING SAME | SHOWA DENKO KK (JP) | 2016-08-24 | — | — | EP | disclosed |
| EP-2248511-B1 | HAIR WASHING COMPOSITION | KAO CORP (JP) | 2015-11-25 | — | — | EP | disclosed |
| US-9180079-B2 | Skin external preparation and method of producing same | SHOWA DENKO K.K. (JP) | 2015-11-10 | — | — | US | disclosed |
| US-8741825-B2 | Hair washing composition | KAO CORPORATION (JP) | 2014-06-03 | — | — | US | disclosed |
| WO-2005102267-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING TOCOPHEROL DERIVATIVE, ASCORBIC ACID DERIVATIVE AND SURFACE ACTIVE AGENT HAVING LIPOPEPTIDE STRUCTURE | SHOWA DENKO K.K. (JP) | 2005-11-03 | — | — | WO | disclosed |
| WO-2005094777-A1 | EXTERNAL PREPARATION FOR SKIN | SHOWA DENKO K.K. (JP) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005095462-A1 | MOISTURE RETENTION POLYMER COMPOUND | SHOWA DENKO K.K. (JP) | 2005-10-13 | — | — | WO | disclosed |
| US-20050220744-A1 | Polysaccharide/functional compound complex | SHOWA DENKO K.K. | 2005-10-06 | — | — | US | disclosed |
| WO-2005092285-A1 | A SKIN CARE AND COSMETIC PREPARATION CONTAINING AN INOSITOL DERIVATIVE | SHOWA DENKO K.K. (JP) | 2005-10-06 | — | — | WO | disclosed |
| WO-2005089708-A1 | OIL-IN-WATER EMULSIFIED COMPOSITION, AND EXTERNAL PREPARATION FOR SKIN AND COSMETICS USING THE COMPOSITION | SHOWA DENKO K.K. (JP) | 2005-09-29 | — | — | WO | disclosed |
| WO-2005074881-A2 | METHOD FOR STABILIZING OIL-BASED THICKENING GEL COMPOSITION | SHOWA DENKO K.K. (JP) | 2005-08-18 | — | — | WO | disclosed |
| WO-2005034903-A1 | AGENT FOR SKIN EXTERNAL USE CONTAINING SALT OF ASCORBIC ACID DERIVATIVE, METHOD FOR STABILIZING THE AGENT FOR SKIN EXTERNAL USE, AND STABILIZER | SHOWA DENKO K.K. (JP) | 2005-04-21 | — | — | WO | disclosed |
| WO-2005020950-A1 | COSMETIC COMPOSITION COMPRISING A AND A LIPOPEPTIDE | SHOWA DENKO K.K. (JP) | 2005-03-10 | — | — | WO | disclosed |
| US-20040210077-A1 | Monocarboxylic acid esters of propoxylated fatty alcohols as pigment dispersants | CRODA, INC. | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260050231-A1 | PROCESS CARTRIDGE | VMA21, ARCN1, CDH1 | ESR1 1381/4885CES2 3251/4885MEN1 2990/4885 |
| US-20260064038-A1 | DEVELOPING ROLLER, PROCESS CARTRIDGE, AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS | CUTA, CA3, C3AR1 | ESR1 2428/4885CES2 3181/4885MEN1 3447/4885 |
| US-20040210077-A1 | Monocarboxylic acid esters of propoxylated fatty alcohols as pigment dispersants | MITF, ELOVL5, ADH5 | ESR1 3194/4885CES2 1509/4885MEN1 2104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.